$VTVT
vTv Therapeutics Inc.

2020 Q3 Form 10-Q Financial Statement

#000156459020051377 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $7.000K $8.000K $1.828M
YoY Change -12.5% -99.76% -26.08%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.070M $1.770M $2.390M
YoY Change -39.55% -18.06% -12.77%
% of Gross Profit
Research & Development $1.768M $3.663M $4.228M
YoY Change -51.73% 35.77% -50.8%
% of Gross Profit
Depreciation & Amortization $20.00K $0.00 $10.00K
YoY Change -100.0% -75.0%
% of Gross Profit
Operating Expenses $2.839M $5.433M $6.620M
YoY Change -47.75% 11.88% -41.58%
Operating Profit -$2.832M -$5.425M -$4.792M
YoY Change -47.8% 266.31% -45.9%
Interest Expense -$240.0K -$390.0K $514.0K
YoY Change -38.46% -51.85% -40.92%
% of Operating Profit
Other Income/Expense, Net $810.0K -$150.0K $1.000K
YoY Change -640.0% -1600.0% -99.69%
Pretax Income -$2.250M -$5.960M -$5.014M
YoY Change -62.25% 204.08% -46.64%
Income Tax $0.00 $0.00 $100.0K
% Of Pretax Income
Net Earnings -$1.533M -$3.608M -$2.882M
YoY Change -57.51% 353.27% -6.18%
Net Earnings / Revenue -21900.0% -45100.0% -157.66%
Basic Earnings Per Share
Diluted Earnings Per Share -$31.72K -$112.4K -$102.7K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.800M $2.400M $1.500M
YoY Change -25.0% -36.84% 25.0%
Cash & Equivalents $1.827M $2.436M $1.462M
Short-Term Investments
Other Short-Term Assets $1.800M $1.200M $500.0K
YoY Change 50.0% -42.86% -80.77%
Inventory
Prepaid Expenses
Receivables $0.00 $10.00K $1.822M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.700M $3.567M $3.796M
YoY Change 3.73% -39.54% -36.82%
LONG-TERM ASSETS
Property, Plant & Equipment $900.0K $46.00K $54.00K
YoY Change 1856.52% -77.0% -73.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.500M $2.500M $2.500M
YoY Change 0.0% 0.0% 0.0%
Other Assets $0.00 $2.900M $2.600M
YoY Change -100.0% 16.0% 4.0%
Total Long-Term Assets $3.300M $5.555M $5.276M
YoY Change -40.59% 6.83% 1.62%
TOTAL ASSETS
Total Short-Term Assets $3.700M $3.567M $3.796M
Total Long-Term Assets $3.300M $5.555M $5.276M
Total Assets $7.000M $9.122M $9.072M
YoY Change -23.26% -17.82% -19.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.700M $6.900M $8.300M
YoY Change -17.39% -23.33% -36.64%
Accrued Expenses $100.0K $100.0K $200.0K
YoY Change 0.0%
Deferred Revenue $31.00K $27.00K
YoY Change -99.54% -99.73%
Short-Term Debt $334.0K $358.0K $0.00
YoY Change -6.7% -16.94%
Long-Term Debt Due $2.400M $7.400M $8.600M
YoY Change -67.57% -22.92% 4.88%
Total Short-Term Liabilities $8.300M $14.46M $17.18M
YoY Change -42.61% -42.86% -45.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.400M $2.200M
YoY Change -100.0% -83.72% -79.82%
Other Long-Term Liabilities $4.500M $260.0K $260.0K
YoY Change 1630.77% -78.33% 1.56%
Total Long-Term Liabilities $4.500M $260.0K $260.0K
YoY Change 1630.77% -97.35% 1.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.300M $14.46M $17.18M
Total Long-Term Liabilities $4.500M $260.0K $260.0K
Total Liabilities $58.40M $19.00M $21.91M
YoY Change 207.32% -65.51% -49.52%
SHAREHOLDERS EQUITY
Retained Earnings -$223.7M -$217.6M
YoY Change 18.38% 5.34%
Common Stock $176.0M $167.1M
YoY Change 21.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$51.37M -$47.15M -$49.90M
YoY Change
Total Liabilities & Shareholders Equity $7.000M $9.122M $9.072M
YoY Change -23.26% -17.74% -19.19%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$1.533M -$3.608M -$2.882M
YoY Change -57.51% 353.27% -6.18%
Depreciation, Depletion And Amortization $20.00K $0.00 $10.00K
YoY Change -100.0% -75.0%
Cash From Operating Activities -$5.440M -$6.190M -$5.500M
YoY Change -12.12% -1.12% -41.05%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $310.0K $0.00
YoY Change
Cash From Investing Activities $310.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 870.0K 6.860M 2.000M
YoY Change -87.32% -22.66% -49.49%
NET CHANGE
Cash From Operating Activities -5.440M -6.190M -5.500M
Cash From Investing Activities 310.0K 0.000
Cash From Financing Activities 870.0K 6.860M 2.000M
Net Change In Cash -4.570M 980.0K -3.500M
YoY Change -566.33% -62.45% -34.82%
FREE CASH FLOW
Cash From Operating Activities -$5.440M -$6.190M -$5.500M
Capital Expenditures $0.00
Free Cash Flow -$6.190M
YoY Change -0.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
806000
CY2019Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
250000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-49902000
us-gaap Operating Expenses
OperatingExpenses
17261000
CY2019Q3 vtvt Stock Issued During Period Value Conversion Of Convertible Securities Related Party
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty
9000000
vtvt Proceeds From Issuance Of Common Stock To Related Party
ProceedsFromIssuanceOfCommonStockToRelatedParty
19500000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5443000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2838000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
543000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
2480000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14504000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-69528000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
171000
CY2020Q3 vtvt Stock Issued During Period Under Atm Offering Value
StockIssuedDuringPeriodUnderATMOfferingValue
2451000
CY2020Q3 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
17067000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
413000
CY2019Q3 vtvt Adjustments To Additional Paid In Capital Letter Agreement And Warrants Issued To Related Party
AdjustmentsToAdditionalPaidInCapitalLetterAgreementAndWarrantsIssuedToRelatedParty
492000
CY2019Q3 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-2560000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-47149000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
737000
vtvt Stock Issued During Period Under Atm Offering Value
StockIssuedDuringPeriodUnderATMOfferingValue
9731000
vtvt Stock Issued During Period Value Conversion Of Convertible Securities Related Party
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty
7000000
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-10192000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-82853000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1095000
vtvt Stock Issued During Period Under Direct Offering Value
StockIssuedDuringPeriodUnderDirectOfferingValue
5443000
vtvt Adjustments To Additional Paid In Capital Letter Agreement And Warrants Issued To Related Party
AdjustmentsToAdditionalPaidInCapitalLetterAgreementAndWarrantsIssuedToRelatedParty
492000
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
18803000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
312000
vtvt Increase Decrease In Long Term Deposits
IncreaseDecreaseInLongTermDeposits
408000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-788000
vtvt Accreted Interest On Debt
AccretedInterestOnDebt
750000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-16000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2450000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
753000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4277000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1827000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4936000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1748000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-178000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15788000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17142000
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
310000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
310000
vtvt Proceeds From Issuance Of Common Stock To Related Party
ProceedsFromIssuanceOfCommonStockToRelatedParty
7000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9731000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3893000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7858000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13338000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17585000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4183000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, the Company evaluates its estimates, including those related to the grant date fair value of equity awards, the fair value of warrants to purchase shares of its Class A Common Stock, the fair value of the Class B Common Stock, the useful lives of property and equipment, the fair value of derivative liabilities, and the fair value of the Company&#8217;s debt, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions. The balances of these cash accounts frequently exceed insured limits.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One and three customers represented 100% of the revenue earned during the three and nine months ended September 30, 2019, respectively.&nbsp;&nbsp;Revenue for the three and nine months ended September 30, 2020 was insignificant. </p>
CY2020Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3000000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1048000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1064000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.2037
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0039
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2531143
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
86250
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
17202
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2600191
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1837065
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2552591
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y10M24D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.19
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.65
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.24
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.08
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.63
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.15
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
737000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1095000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1313000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4896000
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
334000
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
144000
CY2020Q3 vtvt Accreted Final Payment
AccretedFinalPayment
-722000
CY2019Q4 vtvt Accreted Final Payment
AccretedFinalPayment
-1132000
CY2020Q3 us-gaap Notes Payable
NotesPayable
2369000
CY2019Q4 us-gaap Notes Payable
NotesPayable
6172000
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.131
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.131
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
62000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
255000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
261000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
268000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
275000
CY2020Q3 vtvt Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
23000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1144000
CY2020Q3 vtvt Operating Leases Imputed Interest
OperatingLeasesImputedInterest
278000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
866000
CY2020Q3 vtvt Redeemable Noncontrolling Interest Temporary Equity Redemption Value
RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue
45600000
CY2019Q4 vtvt Redeemable Noncontrolling Interest Temporary Equity Redemption Value
RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue
40200000
CY2020Q3 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
875000
CY2019Q3 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
4515000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
6303000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
14408000
CY2020Q3 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-2408000
CY2019Q3 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-8630000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-15928000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-27288000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q3 vtvt Deemed Distribution To Related Party
DeemedDistributionToRelatedParty
507000
vtvt Deemed Distribution To Related Party
DeemedDistributionToRelatedParty
4235000
CY2020Q3 vtvt Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-1533000
CY2019Q3 vtvt Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-4115000
vtvt Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-9625000
vtvt Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-12880000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29583915
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32730515
us-gaap Restructuring And Related Activities Initiation Date
RestructuringAndRelatedActivitiesInitiationDate
2018-12-11
us-gaap Payments For Restructuring
PaymentsForRestructuring
300000
CY2020Q3 us-gaap Severance Costs1
SeveranceCosts1
0
us-gaap Severance Costs1
SeveranceCosts1
0
CY2020Q4 vtvt Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
2800000

Files In Submission

Name View Source Status
0001564590-20-051377-index-headers.html Edgar Link pending
0001564590-20-051377-index.html Edgar Link pending
0001564590-20-051377.txt Edgar Link pending
0001564590-20-051377-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gstaeifrifan000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtvt-10q_20200930.htm Edgar Link pending
vtvt-20200930.xml Edgar Link completed
vtvt-20200930.xsd Edgar Link pending
vtvt-20200930_cal.xml Edgar Link unprocessable
vtvt-20200930_def.xml Edgar Link unprocessable
vtvt-20200930_lab.xml Edgar Link unprocessable
vtvt-20200930_pre.xml Edgar Link unprocessable
vtvt-ex311_7.htm Edgar Link pending
vtvt-ex312_8.htm Edgar Link pending
vtvt-ex321_9.htm Edgar Link pending
vtvt-ex322_6.htm Edgar Link pending